Its also worth naming the other side of this: a regulated pipeline through pharmacies doesnt just make existing use safer it almost certainly expands who tries it, given the legitimacy a pharmacist dispensing it implies
Research overwhelmingly describes the safety of GHK-Cu positively, such as when the authors of a 2018 review called it a safe, inexpensive, extensively studied compound.14 However, even though copper peptides have demonstrated an impressive safety track record in studies, there are (as with most skin care actives) a few safety risks to consider
Unfortunately, some want to profit from trends and have little concern about whether a product will deliver the promised results, and even less concern about whether it ends up doing people more harm than good
Intermediate values were observed for liraglutide (11 days, IQR 257), tirzepatide (19 days, IQR 369), lixisenatide (20 days, IQR 5116), and semaglutide (27 days, IQR 577) (Table S6)
As you titrate up through higher doses , the 10mg vial becomes less economical